Clinical Glutathione By EuroMedica Overview & Drug Interactions
Check For Interactions With Clinical Glutathione
Supplement: Clinical Glutathione by EuroMedica
Clinical Glutathione Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
L-Glutathione
| Ingredient Group | Gluthathione |
|---|---|
| Category | non-nutrient/non-botanical |
Drugs that interact with Clinical Glutathione by EuroMedica
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Clinical Glutathione. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
2 Slow Melt Tablet(s)
|
| Maximum serving Sizes: |
2 Slow Melt Tablet(s)
|
| Servings per container | 30 |
| UPC/BARCODE | 367703737061 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| L-Glutathione |
300 mg
|
Gluthathione |
--
|
| Other Ingredients: |
Maltitol
Hydroxypropyl Methylcellulose
Vanilla flavor
Pomegranate (Punica granatum) fruit extract
Vegetable Source Magnesium Stearate
Stevia
|
|---|
Label Statments:
| General Statements |
- Proven active form
- 230% greater blood ratios
- Proven stability
230% improvement
- Blood GSH/GSSG ratio compared to unprotected glutathione
|
|---|---|
| Brand IP Statement(s) |
- Sublinthion
Patented protection system
- Product of France
French patent #FR2972327
- Sublinthion is a unique, protected, patented process from France. In a published human study, Clinical Glutathione with Sublinthion improved the reduced glutathione vs. oxidized ratios in the body by 230%.
- Clinical Glutathione
Unprotected Glutathione
+230%
Blood ratios of active glutathione to oxidized glutathione between day 1 and day 21 after supplementation.
|
| Formula |
- Patented, reduced oral glutathione for vital support
|
| FDA Statement of Identity |
- Dietary Supplement
|
| Formulation |
- Vegan
- No sugar, salt, wheat, gluten, corn, soy, dairy products, artificial coloring, or artificial preservatives.
|
| FDA Disclaimer Statement |
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| General |
- JC 34 91 + 3(5,6)EP BX73706.03
|
| Suggested/Recommended/Usage/Directions |
- Recommendations: Take 2 tablets daily. One tablet in a.m. and one tablet in the p.m., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.
|
| Precautions |
- If pregnant or nursing, consult a healthcare practitioner before using.
|
Brand Information
See all products by this brand
| Manufactured by a cGMP compliant facility exclusively for: | |
|---|---|
| Name | EuroMedica |
| Street Address | 955 Challenger Dr. |
| City | Green Bay |
| State | WI |
| ZipCode | 54311 |
| Phone Number | 866-842-7256 |
| Web Address | www.EuroMedicaUSA.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.